Topical GHK-Cu Gel for Acute Skin Wound Healing

Phase 2 Recruiting 60 enrolled Hudson Biotech

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate whether a topical gel containing GHK-Cu (a copper(II)-peptide complex) can safely speed up healing of small, standardized skin wounds in healthy adults compared with a matching vehicle gel. Participants will receive two small punch-biopsy wounds on the upper arm; each wound will be randomly assigned to receive GHK-Cu gel or vehicle gel under identical dressings. Wounds will be photographed and assessed over 3 weeks, with a follow-up visit to evaluate scar quality.

Timeline

Start: 2026-02-02
Primary completion: 2027-02-14
Completion: 2028-03-17

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	GHK-Cu	Peptide	0.1 %	Topical
Subject	GHK-Cu	Peptide	0.5 g	Topical

Indications

No indication recorded.